共 35 条
- [1] Macmahon S.W., Cutler J.A., Furberg C.D., Et al., He effects of drug treatment of hypertension on morbidity and mortality from cardiovascular disease: A review of randomized controlled trials, Prog Cardiovasc Dis, 29, pp. 99-118, (1986)
- [2] Collins R., Peto R., Macmahon S., Et al., Blood pressure, stroke, and coronary heart disease, Part 2. Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context, Lancet, 335, pp. 827-838, (1990)
- [3] Ames R.P., Metabolic disturbances increasing the risk of coronary heart disease during diuretic-based antihypertensive therapy: Lipid alterations and glucose intolerance, Am Heart J, 106, pp. 1207-1214, (1983)
- [4] Leren P., Helgeland A., Holme I., Et al., Effect of propanolol and prazosin on blood lipids: The Oslo Study, The Lancet, 2, pp. 2-6, (1980)
- [5] Weinberger M.H., Antihypertensive therapy and lipids: Paradoxical influences on cardiovascular disease risk, Am J Med, 80, pp. 64-70, (1986)
- [6] Rohling J.J., Brunzell J.D., The effects of diuretics and adrenergic-blocking agents on plasma lipids, West J Med, 145, pp. 210-218, (1986)
- [7] Lucas C.P., Estigarribia J.A., Darga L.L., Et al., Insulin and blood pressure in obesity, Hypertension, 7, pp. 702-706, (1985)
- [8] Modan M., Halkin H., Almog S., Et al., Hyperinsulinemia: A link between hypertension, obesity and glucose intolerance, J Clin Invest, 75, pp. 809-817, (1985)
- [9] Ferrannini E., Buzzigoli G., Bonadona R., Insulin resistance in essential hypertension, N Engl J Med, 317, pp. 350-357, (1987)
- [10] Fuh M.-T., Shieh S.M., Wu D.-A., Et al., Abnormalities of carbohydrate and lipid metabolism in patients with hypertension, Arch Intern Med, 147, pp. 1035-1038, (1987)